Formulation Design of Dry Powders for Inhalation

Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may also be amorphous small molecules, peptides, antibodies, and myriad types of engineered proteins. The evolution of respiratory therapeutics has created a need for flexible formulation technologies to engineer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pharmaceutical sciences 2015-10, Vol.104 (10), p.3259-3288
Hauptverfasser:	Weers, Jeffry G., Miller, Danforth P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation aerosols Algorithms amorphous Chemistry, Pharmaceutical - standards dry powder inhaler Dry Powder Inhalers - standards engineered particles excipients Humans inhalation Inhaled by design Particle Size powder technology Powders - standards protein delivery pulmonary delivery/adsorption
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!